EKF — EKF Diagnostics Holdings Cashflow Statement
0.000.00%
- £94.82m
- £82.73m
- £50.19m
- 92
- 59
- 34
- 70
Annual cashflow statement for EKF Diagnostics Holdings, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 15.4 | 21.4 | -8.94 | 2.13 | 6.26 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 4.93 | -6.45 | 16.7 | 2.27 | 0.518 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -11.1 | -10.6 | -4.68 | -3.56 | 2.15 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 13.8 | 10.2 | 9.69 | 6.31 | 13.7 |
Capital Expenditures | -2.65 | -5.65 | -5.83 | -6.97 | -2.76 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 3.98 | 0.172 | -3.1 | 1.33 | 0.094 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 1.34 | -5.48 | -8.93 | -5.64 | -2.66 |
Financing Cash Flow Items | -0.209 | -0.231 | 0 | -0.185 | -0.336 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -5.21 | -6.16 | -11 | -3.65 | -4.08 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 9.84 | -1.57 | -8.76 | -3.85 | 6.58 |